Drug application
RHUZDAH (ETHINYL ESTRADIOL, NORETHINDRONE)
Drugs@FDA ANDA 207585 · AUROBINDO PHARMA
Key facts
| Drug name | RHUZDAH |
|---|---|
| Active ingredients | ETHINYL ESTRADIOL, NORETHINDRONE |
| Application type | ANDA |
| Application number | 207585 |
| Company | AUROBINDO PHARMA |
| Dosage forms | TABLET, ORAL-28 |
| Strength | 0.035MG;0.4MG |
| Marketing status | Discontinued |
| TE codes | AB |
| Reference listed drug | No |
| Latest submission status date | Oct 11, 2022 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 10–99 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.